Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 2
1984 1
1985 1
1986 1
1988 1
1989 2
1990 1
1991 1
1992 1
1993 3
1995 3
1996 1
1997 2
1999 1
2000 2
2003 1
2004 3
2005 2
2006 2
2007 1
2008 1
2009 3
2010 1
2013 1
2014 2
2015 1
2016 4
2017 3
2018 1
2019 1
2020 2
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Abnormal lymphocyte surface marker expression"
Page 1
CD160 receptor in CLL: Current state and future avenues.
Oumeslakht L, Aziz AI, Bensussan A, Ben Mkaddem S. Oumeslakht L, et al. Front Immunol. 2022 Nov 7;13:1028013. doi: 10.3389/fimmu.2022.1028013. eCollection 2022. Front Immunol. 2022. PMID: 36420268 Free PMC article. Review.
CD160 is a glycosylphosphatidylinositol (GPI)-anchored cell surface glycoprotein expressed on cytotoxic natural killer (NK) cells and T-cell subsets. ...It also modulates the immune system and is involved in some pathologies, such as cancer. CD160 is abnormally …
CD160 is a glycosylphosphatidylinositol (GPI)-anchored cell surface glycoprotein expressed on cytotoxic natural killer (NK) ce …
Expression of CD markers' in immune thrombocytopenic purpura: prognostic approaches.
Behzad MM, Asnafi AA, Jaseb K, Jalali Far MA, Saki N. Behzad MM, et al. APMIS. 2017 Dec;125(12):1042-1055. doi: 10.1111/apm.12755. Epub 2017 Sep 28. APMIS. 2017. PMID: 28960510 Review.
T and B lymphocytes are the main immune cells in the body. Defective function causes disrupted balance of different subgroups of lymphocytes, and abnormal expression of surface markers of these cells results in self-tolerance dysfunction, …
T and B lymphocytes are the main immune cells in the body. Defective function causes disrupted balance of different subgroups of l …
Aberrant expression of T cell activation markers and upregulation of Tregs in bone marrow and peripheral blood in acute myeloid leukemia patients.
Fang J, Zhang R, Lin X, Xu Y, Huang K, Saw PE. Fang J, et al. Hematology. 2023 Dec;28(1):2219554. doi: 10.1080/16078454.2023.2219554. Hematology. 2023. PMID: 37288810
METHODS: Expression of CD25, CD38, CD69, and HLA-DR on the surfaces of CD4(+) and CD8(+) T cells and the quantity of Tregs in BM and PB from new diagnosed (ND), relapsed-refractory (RR), complete remission (CR) AML patients were measured via flow cytometry. ...Our r …
METHODS: Expression of CD25, CD38, CD69, and HLA-DR on the surfaces of CD4(+) and CD8(+) T cells and the quantity of Tregs in …
Multiple myeloma and chronic lymphocytic leukemia.
Rosen L, Vescio R, Berenson JR. Rosen L, et al. Curr Opin Hematol. 1995 Jul;2(4):275-82. doi: 10.1097/00062752-199502040-00007. Curr Opin Hematol. 1995. PMID: 9372008 Review.
For myeloma, its lack of CD34 expression can lead to a functional but less contaminated autograft for stem cell transplantation. ...Cell surface markers and cytogenetic abnormalities continue to identify patients with poor prognoses. ...
For myeloma, its lack of CD34 expression can lead to a functional but less contaminated autograft for stem cell transplantation. ...C …
CD markers variations in chronic lymphocytic leukemia: New insights into prognosis.
Vosoughi T, Bagheri M, Hosseinzadeh M, Ehsanpour A, Davari N, Saki N. Vosoughi T, et al. J Cell Physiol. 2019 Nov;234(11):19420-19439. doi: 10.1002/jcp.28724. Epub 2019 May 2. J Cell Physiol. 2019. PMID: 31049958 Review.
Different pathogenesis factors can contribute to the aggression of the clinical course in this disease. Cytogenetic abnormalities and surface biomarkers of neoplastic CLL cells can be effective in the outcome of CLL, and the examination of changing CD mark …
Different pathogenesis factors can contribute to the aggression of the clinical course in this disease. Cytogenetic abnormalities …
Identification of regulatory T cells in systemic lupus erythematosus.
Gerli R, Nocentini G, Alunno A, Bocci EB, Bianchini R, Bistoni O, Riccardi C. Gerli R, et al. Autoimmun Rev. 2009 Mar;8(5):426-30. doi: 10.1016/j.autrev.2009.01.004. Epub 2009 Feb 8. Autoimmun Rev. 2009. PMID: 19185065 Review.
This may depend on the selection of patients with different degrees of disease activity or on immunosuppressive treatments that can alter Treg cell findings. Among several proposed surface or intracellular Treg cell markers, CD25 at high level of expression a …
This may depend on the selection of patients with different degrees of disease activity or on immunosuppressive treatments that can alter Tr …
Morphological and immunophenotypic features of chronic lymphocytic leukemia.
Matutes E, Polliack A. Matutes E, et al. Rev Clin Exp Hematol. 2000 Mar;4(1):22-47. doi: 10.1046/j.1468-0734.2000.00002.x. Rev Clin Exp Hematol. 2000. PMID: 11486329 Review.
The latter marker identifies an extracellular epitope of the B-cell receptor (BCR) beta chain and its weak or absent expression in CLL may derive from the expression of a truncated form. This, together with the low expression of CD22, might explain the …
The latter marker identifies an extracellular epitope of the B-cell receptor (BCR) beta chain and its weak or absent expression …
Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia.
Mroczek A, Zawitkowska J, Kowalczyk J, Lejman M. Mroczek A, et al. Int J Mol Sci. 2021 Jan 15;22(2):808. doi: 10.3390/ijms22020808. Int J Mol Sci. 2021. PMID: 33467425 Free PMC article. Review.
The diagnosis of T-ALL is based on morphologic, immunophenotypic, cytogenetic, and molecular features, thus the results are used for patient stratification. Due to the expression of surface and intracellular antigens, several subtypes of T-ALL can be distinguished. …
The diagnosis of T-ALL is based on morphologic, immunophenotypic, cytogenetic, and molecular features, thus the results are used for patient …
Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL.
D'Avola A, Drennan S, Tracy I, Henderson I, Chiecchio L, Larrayoz M, Rose-Zerilli M, Strefford J, Plass C, Johnson PW, Steele AJ, Packham G, Stevenson FK, Oakes CC, Forconi F. D'Avola A, et al. Blood. 2016 Aug 11;128(6):816-26. doi: 10.1182/blood-2016-03-707786. Epub 2016 Jun 14. Blood. 2016. PMID: 27301861 Free article.
Chronic lymphocytic leukemia (CLL) with unmutated (U-CLL) or mutated (M-CLL) immunoglobulin gene heavy-chain variable region (IGHV) displays different states of anergy, indicated by reduced surface immunoglobulin M (sIgM) levels and signaling, consequent to c …
Chronic lymphocytic leukemia (CLL) with unmutated (U-CLL) or mutated (M-CLL) immunoglobulin gene heavy-chain variable region ( …
MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia.
Mraz M, Kipps TJ. Mraz M, et al. Leuk Lymphoma. 2013 Aug;54(8):1836-9. doi: 10.3109/10428194.2013.796055. Epub 2013 Jun 12. Leuk Lymphoma. 2013. PMID: 23597135 Free PMC article. Review.
The relative expression levels of certain microRNAs (miRNAs) correlate with known prognostic markers in chronic lymphocytic leukemia (CLL), such as leukemia-cell expression of zeta-associated protein of 70 kDa (ZAP-70), use of unmutated immunogl …
The relative expression levels of certain microRNAs (miRNAs) correlate with known prognostic markers in chronic lymp …
56 results